Earnings Preview: TherapeuticsMD (TXMD) Q2 Earnings Expected to DeclineZacks Investment Research • 07/22/19
TherapeuticsMD: The Most Undervalued Drug/Device/Biotech Commercial Manufacturer In A GenerationSeeking Alpha • 07/19/19
TherapeuticsMD, Inc. (TXMD) CEO Robert Finizio on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/07/19